217 related articles for article (PubMed ID: 23124635)
1. Diffusion-weighted MRI: distinction of skull base chordoma from chondrosarcoma.
Yeom KW; Lober RM; Mobley BC; Harsh G; Vogel H; Allagio R; Pearson M; Edwards MS; Fischbein NJ
AJNR Am J Neuroradiol; 2013 May; 34(5):1056-61, S1. PubMed ID: 23124635
[TBL] [Abstract][Full Text] [Related]
2. Is there a role for conventional MRI and MR diffusion-weighted imaging for distinction of skull base chordoma and chondrosarcoma?
Müller U; Kubik-Huch RA; Ares C; Hug EB; Löw R; Valavanis A; Ahlhelm FJ
Acta Radiol; 2016 Feb; 57(2):225-32. PubMed ID: 25722460
[TBL] [Abstract][Full Text] [Related]
3. Radiomic analysis of multiparametric magnetic resonance imaging for differentiating skull base chordoma and chondrosarcoma.
Li L; Wang K; Ma X; Liu Z; Wang S; Du J; Tian K; Zhou X; Wei W; Sun K; Lin Y; Wu Z; Tian J
Eur J Radiol; 2019 Sep; 118():81-87. PubMed ID: 31439263
[TBL] [Abstract][Full Text] [Related]
4. Diagnostic accuracy of DW MR imaging in the differentiation of chordomas and chondrosarcomas of the skull base: A 3.0-T MRI study of 105 cases.
Welzel T; Meyerhof E; Uhl M; Huang K; von Deimling A; Herfarth K; Debus J
Eur J Radiol; 2018 Aug; 105():119-124. PubMed ID: 30017267
[TBL] [Abstract][Full Text] [Related]
5. Differentiating skull base chordomas and invasive pituitary adenomas with conventional MRI.
Gao A; Bai J; Cheng J; Cheng X; Li S; Zhang Z; Zhang Y
Acta Radiol; 2018 Nov; 59(11):1358-1364. PubMed ID: 29448805
[TBL] [Abstract][Full Text] [Related]
6. Revisitation of imaging features of skull base chondrosarcoma in comparison to chordoma.
Hasegawa H; Shin M; Niwa R; Koizumi S; Yoshimoto S; Shono N; Shinya Y; Takami H; Tanaka S; Umekawa M; Amemiya S; Kin T; Saito N
J Neurooncol; 2022 Sep; 159(3):581-590. PubMed ID: 35882753
[TBL] [Abstract][Full Text] [Related]
7. Analysis of radiological features relative to histopathology in 42 skull-base chordomas and chondrosarcomas.
Pamir MN; Ozduman K
Eur J Radiol; 2006 Jun; 58(3):461-70. PubMed ID: 16631334
[TBL] [Abstract][Full Text] [Related]
8. Chondrosarcoma of the base of the skull: a clinicopathologic study of 200 cases with emphasis on its distinction from chordoma.
Rosenberg AE; Nielsen GP; Keel SB; Renard LG; Fitzek MM; Munzenrider JE; Liebsch NJ
Am J Surg Pathol; 1999 Nov; 23(11):1370-8. PubMed ID: 10555005
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of skull base chordomas from chondrosarcomas by diffusion-weighted MRI.
Freeze BS; Glastonbury CM
AJNR Am J Neuroradiol; 2013 Oct; 34(10):E113. PubMed ID: 23945231
[No Abstract] [Full Text] [Related]
10. MR Imaging Grading System for Skull Base Chordoma.
Tian K; Wang L; Ma J; Wang K; Li D; Du J; Jia G; Wu Z; Zhang J
AJNR Am J Neuroradiol; 2017 Jun; 38(6):1206-1211. PubMed ID: 28428207
[TBL] [Abstract][Full Text] [Related]
11. [Magnetic resonance (MR) imaging of chordoma and chondroma in the skull base--differential diagnosis by IR sequence].
Tashiro T; Inoue Y; Nemoto Y; Shakudo M; Mochizuki K; Yahata S; Tada T; Hata M; Oda J; Onoyama Y
Nihon Igaku Hoshasen Gakkai Zasshi; 1992 May; 52(5):589-93. PubMed ID: 1508632
[TBL] [Abstract][Full Text] [Related]
12. Differentiation of Skull Base Chondrosarcomas, Chordomas, and Metastases: Utility of DWI and Dynamic Contrast-Enhanced Perfusion MR Imaging.
Ota Y; Liao E; Capizzano AA; Baba A; Kurokawa R; Kurokawa M; Srinivasan A
AJNR Am J Neuroradiol; 2022 Sep; 43(9):1325-1332. PubMed ID: 35953276
[TBL] [Abstract][Full Text] [Related]
13. Chordoma and chondrosarcoma: similar, but quite different, skull base tumors.
Almefty K; Pravdenkova S; Colli BO; Al-Mefty O; Gokden M
Cancer; 2007 Dec; 110(11):2457-67. PubMed ID: 17894390
[TBL] [Abstract][Full Text] [Related]
14. Apparent diffusion coefficient as a prognostic factor in clival chordoma.
Oh HC; Hong CK; Lee KS; Cha YJ; Ahn SJ; Suh SH; Park HH
Sci Rep; 2021 Jan; 11(1):486. PubMed ID: 33436803
[TBL] [Abstract][Full Text] [Related]
15. Is there a role for diffusion-weighted MRI (DWI) in the diagnosis of central cartilage tumors?
Douis H; Jeys L; Grimer R; Vaiyapuri S; Davies AM
Skeletal Radiol; 2015 Jul; 44(7):963-9. PubMed ID: 25744812
[TBL] [Abstract][Full Text] [Related]
16. Urinary bladder cancer: diffusion-weighted MR imaging--accuracy for diagnosing T stage and estimating histologic grade.
Takeuchi M; Sasaki S; Ito M; Okada S; Takahashi S; Kawai T; Suzuki K; Oshima H; Hara M; Shibamoto Y
Radiology; 2009 Apr; 251(1):112-21. PubMed ID: 19332849
[TBL] [Abstract][Full Text] [Related]
17. Small (< 4 cm) Renal Tumors With Predominantly Low Signal Intensity on T2-Weighted Images: Differentiation of Minimal-Fat Angiomyolipoma From Renal Cell Carcinoma.
Park JJ; Kim CK
AJR Am J Roentgenol; 2017 Jan; 208(1):124-130. PubMed ID: 27824487
[TBL] [Abstract][Full Text] [Related]
18. Lymphomas and glioblastomas: differences in the apparent diffusion coefficient evaluated with high b-value diffusion-weighted magnetic resonance imaging at 3T.
Doskaliyev A; Yamasaki F; Ohtaki M; Kajiwara Y; Takeshima Y; Watanabe Y; Takayasu T; Amatya VJ; Akiyama Y; Sugiyama K; Kurisu K
Eur J Radiol; 2012 Feb; 81(2):339-44. PubMed ID: 21129872
[TBL] [Abstract][Full Text] [Related]
19. Diffusion-weighted MRI and in-phase/opposed-phase sequences in the assessment of bone tumors.
Amin WM; Kotb HT; Abdel-Kerim AA; Barakat MS; El-Malky AA; Fadel SH
J Magn Reson Imaging; 2016 Sep; 44(3):565-72. PubMed ID: 26934685
[TBL] [Abstract][Full Text] [Related]
20. Characterization of Parotid Tumors With Dynamic Susceptibility Contrast Perfusion-Weighted Magnetic Resonance Imaging and Diffusion-Weighted MR Imaging.
Abdel Razek AA; Samir S; Ashmalla GA
J Comput Assist Tomogr; 2017 Jan; 41(1):131-136. PubMed ID: 27636248
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
